For Clover Health Investments Corp. [CLOV], Analyst sees a drop to $3. What next?

Clover Health Investments Corp. [NASDAQ: CLOV] plunged by -$0.05 during the normal trading session on Friday and reaching a high of $1.47 during the day while it closed the day at $1.37. The company report on November 3, 2022 that Clover Health to Present at Credit Suisse 31st Annual Healthcare Conference on November 10, 2022.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


A live webcast of the presentation will be accessible from Clover Health’s investor relations website at An archived replay of the presentation will be available from the same website for 12 months following the live presentation.

Clover Health Investments Corp. stock has also loss -12.74% of its value over the past 7 days. However, CLOV stock has declined by -59.71% in the 3 months of the year. Over the past six months meanwhile, it has lost -49.07% and lost -63.17% year-on date.

The market cap for CLOV stock reached $650.27 million, with 476.06 million shares outstanding and 346.06 million shares in the current float. Compared to the average trading volume of 7.66M shares, CLOV reached a trading volume of 12203581 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Clover Health Investments Corp. [CLOV]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $3.58 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Cowen have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on February 02, 2022. While these analysts kept the previous recommendation, Canaccord Genuity raised their target price to Buy. The new note on the price target was released on February 02, 2022, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $3, while SVB Leerink analysts kept a Mkt Perform rating on CLOV stock. On January 10, 2022, analysts decreased their price target for CLOV shares from 9 to 3.50.

The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.12, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 0.25. The Price to Book ratio for the last quarter was 1.52, with the Price to Cash per share for the same quarter was set at 1.10.

CLOV stock trade performance evaluation

Clover Health Investments Corp. [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -12.74. With this latest performance, CLOV shares dropped by -19.41% in over the last four-week period, additionally sinking by -49.07% over the last 6 months – not to mention a drop of -82.18% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 32.76, with the RSI for the last a single of trading hit 31.01, and the three-weeks RSI is set at 34.01 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 1.9376, while it was recorded at 1.4880 for the last single week of trading, and 2.5447 for the last 200 days.

Clover Health Investments Corp. [CLOV]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp. [CLOV] shares currently have an operating margin of -37.11. Clover Health Investments Corp.’s Net Margin is presently recorded at -38.21.

Return on Equity for this stock declined to -88.46, with Return on Assets sitting at -65.05.

Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.20.

Earnings per share (EPS) analysis for Clover Health Investments Corp. [CLOV] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 19.10%.

Clover Health Investments Corp. [CLOV]: Insider Ownership positions

There are presently around $168 million, or 32.50% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 32,095,012, which is approximately 23.028% of the company’s market cap and around 3.20% of the total institutional ownership; BLACKROCK INC., holding 24,435,025 shares of the stock with an approximate value of $33.48 million in CLOV stocks shares; and STATE STREET CORP, currently with $10.89 million in CLOV stock with ownership of nearly 311.373% of the company’s market capitalization.

Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 100 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 50,856,359 shares. Additionally, 60 investors decreased positions by around 22,230,380 shares, while 49 investors held positions by with 49,882,873 shares. The mentioned changes placed institutional holdings at 122,969,612 shares, according to the latest SEC report filing. CLOV stock had 39 new institutional investments in for a total of 4,887,394 shares, while 25 institutional investors sold positions of 4,341,391 shares during the same period.


Please enter your comment!
Please enter your name here